Connect your AI

King Pharmaceuticals KG Medical costs

Segments

By segment

Legacy Reinsurance$2.26M—

Other financials

Income statement

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

Operating cash flow-$15.1M-1,628%

Valuation

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

Net margin131.5%—

Returns & leverage

Return on equity90.8%—

Debt / equity1.5×—